首站-论文投稿智能助手
典型文献
The cell cycle inhibitor P21 promotes the development of pulmonary fibrosis by suppressing lung alveolar regeneration
文献摘要:
The cell cycle inhibitor P21 has been implicated in cell senescence and plays an important role in the injury-repair process following lung injury.Pulmonary fibrosis(PF)is a fibrotic lung disorder characterized by cell senescence in lung alveolar epithelial cells.In this study,we report that P21 expres-sion was increased in alveolar epithelial type 2 cells(AEC2s)in a time-dependent manner following mul-tiple bleomycin-induced PF.Repeated injury of AEC2s resulted in telomere shortening and triggered P21-dependent cell senescence.AEC2s with elevated expression of P21 lost their self-renewal and dif-ferentiation abilities.In particular,elevated P21 not only induced cell cycle arrest in AEC2s but also bound to P300 and β-catenin and inhibited AEC2 differentiation by disturbing the P300-β-catenin inter-action.Meanwhile,senescent AEC2s triggered myofibroblast activation by releasing profibrotic cyto-kines.Knockdown of P21 restored AEC2-mediated lung alveolar regeneration in mice with chronic PF.The results of our study reveal a mechanism of P21-mediated lung regeneration failure during PF development,which suggests a potential strategy for the treatment of fibrotic lung diseases.
文献关键词:
作者姓名:
Xiaoxi Lv;Chang Liu;Shanshan Liu;Yunxuan Li;Wanyu Wang;Ke Li;Fang Hua;Bing Cui;Xiaowei Zhang;Jiaojiao Yu;Jinmei Yu;ZhuoWei Hu
作者机构:
Immunology and Cancer Pharmacology Group,State Key Laboratory of Bioactive Substance and Function of Natural Medicines,Institute of Materia Medica,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100050,China;Drug Clinical Trial Institution,Children's Hospital,Capital Institute of Pediatrics,Beijing 100020,China;Institute of Medicinal Biotechnology,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100050,China
引用格式:
[1]Xiaoxi Lv;Chang Liu;Shanshan Liu;Yunxuan Li;Wanyu Wang;Ke Li;Fang Hua;Bing Cui;Xiaowei Zhang;Jiaojiao Yu;Jinmei Yu;ZhuoWei Hu-.The cell cycle inhibitor P21 promotes the development of pulmonary fibrosis by suppressing lung alveolar regeneration)[J].药学学报(英文版),2022(02):735-746
A类:
AEC2s,AEC2,kines
B类:
cycle,inhibitor,P21,promotes,development,pulmonary,fibrosis,by,suppressing,lung,alveolar,regeneration,has,been,implicated,senescence,plays,important,role,injury,repair,process,following,Pulmonary,PF,disorder,characterized,epithelial,cells,In,this,study,we,report,that,was,increased,type,dependent,manner,mul,tiple,bleomycin,induced,Repeated,resulted,telomere,shortening,triggered,elevated,expression,lost,their,self,renewal,abilities,particular,not,only,arrest,but,also,bound,P300,catenin,inhibited,differentiation,disturbing,inter,action,Meanwhile,senescent,myofibroblast,activation,releasing,profibrotic,cyto,Knockdown,restored,mediated,mice,chronic,results,our,reveal,mechanism,failure,during,which,suggests,potential,strategy,treatment,diseases
AB值:
0.521955
相似文献
N6?methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance
Xian Lin;Feng Wang;Jian Chen;Jing Liu;Yi?Bin Lin;Li Li;Chuan?Ben Chen;Qin Xu-Departments of Gynecology,Fujian Cancer Hospital and Fujian Medical University Cancer Hospital,Fujian Medical University,Fuzhou 350014,China;Department of Radiation Oncology,Fujian Cancer Hospital and Fujian Medical University Cancer Hospital,Fujian Medical University,Fuzhou 350014,China;Shenzhen Key Laboratory of Immunity and Inflammatory Diseases,Peking University Shenzhen Hospital,Shenzhen Peking University?the Hong Kong University of Science and Technology Medical Center,Shenzhen 518036,Guangdong,China;Outpatient Department,Fujian Hospital of People's Armed Police,Fujian Medical University,Fuzhou 350014,China
FGF2 is overexpressed in asthma and promotes airway inflammation through the FGFR/MAPK/NF-κB pathway in airway epithelial cells
Yuan-Yang Tan;Hui-Qin Zhou;Yu-Jing Lin;Liu-Tong Yi;Zhuang-Gui Chen;Qing-Dong Cao;Yan-Rong Guo;Zhao-Ni Wang;Shou-Deng Chen;Yang Li;De-Yun Wang;Yong-Kang Qiao;Yan Yan-Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center,the Fifth Affiliated Hospital,Sun Yat-Sen University,Zhuhai 519000,Guangdong,China;Department of Pathology,the Fifth Affiliated Hospital,Sun Yat-Sen University,Zhuhai 519000,Guangdong,China;Department of Pediatrics,the Third Affiliated Hospital,Sun Yat-Sen University,Guangzhou 510630,China;Department of Cardiothoracic Surgery,the Fifth Affiliated Hospital,Sun Yat-Sen University,Zhuhai 519000,Guangdong,China;Department of Otolaryngology,Yong Loo Lin School of Medicine,National University Health System,National University of Singapore,Singapore 119228,Singapore;BGI-Shenzhen,Shenzhen 518083,Guangdong,China;Central Laboratory,the Fifth Affiliated Hospital,Sun Yat-Sen University,Zhuhai 519000,Guangdong,China
Chalcone derivatives ameliorate lipopolysaccharide-induced acute lung injury and inflammation by targeting MD2
Ya-li Zhang;Wen-xin Zhang;Jue-qian Yan;Ye-lin Tang;Wen-jing Jia;Zheng-wei Xu;Ming-jiang Xu;Nipon Chattipakorn;Yi Wang;Jian-peng Feng;Zhi-guo Liu;Guang Liang-Chemical Biology Research Center,School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou 325035,China;Key Laboratory of Molecular Pharmacology and Drug Evaluation(Yantai University),Ministry of Education,Yantai University,Yantai 264005,China;School of Pharmaceutical Sciences,Hangzhou Medical College,Hangzhou 311399,China;Zhuji Biomedicine Institute,School of Pharmaceutical Sciences,Wenzhou Medical University,Zhuji 311800,China;Cardiac Electrophysiology Research and Training Center,Faculty of Medicine,Chiang Mai University,Chiang Mai 50200,Thailand;Wenzhou Institute,University of Chinese Academy of Sciences,Wenzhou 325001,China
Stratifin promotes renal dysfunction in ischemic and nephrotoxic AKI mouse models via enhancing RIPK3-mediated necroptosis
Fang Wang;Jia-nan Wang;Xiao-yan He;Xiao-guo Suo;Chao Li;Wei-jian Ni;Yu-ting Cai;Yuan He;Xin-yun Fang;Yu-hang Dong;Tian Xing;Ya-ru Yang;Feng Zhang;Xiang Zhong;Hong-mei Zang;Ming-ming Liu;Jun Li;Xiao-ming Meng;Juan Jin-Inflammation and Immune Mediated Diseases Laboratory of Anhui Province,Anhui Institute of Innovative Drugs,School of Pharmacy,Anhui Medical University,The Key Laboratory of Anti-inflammatory of Immune Medicines,Ministry of Education,Hefei 230032,China;Department of Pharmacy,Anhui Provincial Hospital,The First Affiliated Hospital of USTC,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei 230001,China;Hospital of Stomatology,Anhui Medical University,Key Laboratory of Oral Diseases Research of Anhui Province,Hefei 230032,China;Department of Pharmacy,Changzheng Hospital,Naval Medical University,Shanghai 200003,China;Department of Nephrology,Sichuan Academy of Medical Sciences&Sichuan Provincial People's Hospital,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610072,China;School of Basic Medical Sciences,Anhui Medical University,Hefei 230032,China
Discovery of a novel DDRs kinase inhibitor XBLJ-13 for the treatment of idiopathic pulmonary fibrosis
Ying Dong;Bi-xi Tang;Qi Wang;Li-wei Zhou;Cong Li;Xuan Zhang;Dan-dan Sun;Xin Sun;Xue-mei Zhang;Bing Xiong;Jia Li;Hong Shi;Dan-qi Chen;Yi Zang-State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;Department of Pharmacology,School of Pharmacy,Fudan University,Shanghai 201203,China;Department of Medicinal Chemistry,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Center for Supramolecular Chemistry and Catalysis and Department of Chemistry,College of Sciences,Shanghai University,Shanghai 200444,China;Schoolof Chinese Materia Medica,Nanjing University of Chinese Medicine,Nanjing 210023,China;Schoolof Pharmacy,Henan University,Kaifeng 475004,China;Open Studio for Druggability Research of Marine Natural Products,Pilot National Laboratory for Marine Science and Technology(Qingdao),Qingdao 266237,China;School of Pharmaceutical Science and Technology,Hangzhou Institute for Advanced Study,UCAS,Hangzhou 310024,China;Department of Anesthesiology of Shanghai Pulmonary Hospital,School of medicine,Tongji University,Shanghai 200433,China
NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury
Zhi-yong Xie;Wei Dong;Li Zhang;Meng-jie Wang;Zhen-meng Xiao;Yu-hua Zhang;Wan-xin Shi;Ying Huang;Yan Yang;Cui-li Li;Lei Fu;Xing-chen Zhao;Rui-zhao Li;Zhi-lian Li;Yuan-han Chen;Zhi-ming Ye;Shuang-xin Liu;Zheng Dong;Xin-ling Liang-The Second School of Clinical Medicine,Southern Medical University,Guangzhou 510515,China;Division of Nephrology,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China;School of Medicine,South China University of Technology,Guangzhou 510006,China;Department of Cellular Biology and Anatomy,Medical College of Georgia at Augusta University,Augusta,GA,USA;Department of Medical Research,Charlie Norwood Veterans Affairs Medical Center,Augusta,GA,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。